- Home
- MODV vs IMNN Comparison
MODV vs IMNN Comparison
Compare MODV & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- IMNN
- Stock Information
- Founded
- MODV 1996
- IMNN 1982
- Country
- MODV United States
- IMNN United States
- Employees
- MODV N/A
- IMNN N/A
- Industry
- MODV Transportation Services
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- MODV Consumer Discretionary
- IMNN Health Care
- Exchange
- MODV Nasdaq
- IMNN Nasdaq
- Market Cap
- MODV 16.1M
- IMNN 13.6M
- IPO Year
- MODV N/A
- IMNN 1985
- Fundamental
- Price
- MODV $1.17
- IMNN $0.80
- Analyst Decision
- MODV Buy
- IMNN Strong Buy
- Analyst Count
- MODV 4
- IMNN 2
- Target Price
- MODV $8.38
- IMNN $21.50
- AVG Volume (30 Days)
- MODV 505.6K
- IMNN 64.8K
- Earning Date
- MODV 05-08-2025
- IMNN 05-12-2025
- Dividend Yield
- MODV N/A
- IMNN N/A
- EPS Growth
- MODV N/A
- IMNN N/A
- EPS
- MODV N/A
- IMNN N/A
- Revenue
- MODV $2,753,789,000.00
- IMNN N/A
- Revenue This Year
- MODV N/A
- IMNN N/A
- Revenue Next Year
- MODV $5.64
- IMNN N/A
- P/E Ratio
- MODV N/A
- IMNN N/A
- Revenue Growth
- MODV N/A
- IMNN N/A
- 52 Week Low
- MODV $0.96
- IMNN $0.64
- 52 Week High
- MODV $32.82
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- MODV 39.11
- IMNN 38.19
- Support Level
- MODV $1.28
- IMNN $0.79
- Resistance Level
- MODV $1.54
- IMNN $0.84
- Average True Range (ATR)
- MODV 0.21
- IMNN 0.04
- MACD
- MODV 0.06
- IMNN -0.00
- Stochastic Oscillator
- MODV 29.41
- IMNN 8.33
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.